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Background: Middle East respiratory syndrome coronavirus (MERS-CoV) is a virus that causes severe viral
pneumonia in humans, known to have a high mortality rate and a similarity in clinical symptoms with severe acute
respiratory syndrome coronavirus. It was first isolated in Kingdom of Saudi Arabia (KSA) in 2012 and after that,
MERS-CoV exhibited outbreaks in several regions of the world. This study aimed to assess the characteristics of
publications involving MERS-CoV at global level by using a bibliometric analysis.
Methods: Scopus database was searched on March 4, 2016 for MERS-CoV publications published between 2012
and 2015. It was performed on the same day in order to avoid the possible bias came from update on the
database because the metrics are changing over time. All publication types were considered; however publications
as errata were excluded. Analysis parameters include year of publication, publication type, patterns of international
collaboration, research institutions, journals, impact factor, h-index, language, and times cited.
Results: A total of 883 MERS-CoV research publications were published across the world. The MERS-CoV-associated
publications were originated from 92 countries/territories, indicating the international spread of MERS-CoV research.
The USA was the largest contributor, with 319 articles published over 4 years, followed by KSA (113 articles). The
total number of citations for these publications has already achieved 8,015, with an average of 9.01 citations per
each publication. The h-index for MERS-CoV-associated publications was 48. The USA also have the highest h-index
(32), followed by KSA (26) and UK (22). Netherland produced the greatest proportion of publications with
international research collaboration (72.7 %) followed by the UK (71 %) and Germany (69.1 %) out of the total
number of publications for each country.
Conclusions: There is a rapid increase in research activities related to MERS-CoV from 2012 to 2015. This study
demonstrates that the MERS-CoV related literature has grown to be more extensive and global over the past 4 years.
The bulk of publications in the field of MERS-CoV research are published by high-income countries such as the USA.
Furthermore, the USA, the UK and KSA may have higher quality of articles according to the value of h-index.
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Background
Middle East respiratory syndrome coronavirus (MERS-
CoV) is a virus that causes severe viral pneumonia in
humans, known as having a high mortality rate and having
a similarity in clinical symptoms with severe acute respira-
tory syndrome coronavirus [1–3]. It was first happened in
Jordan in April, 2012 [4], and then the virus was isolated
from a patients in Kingdom of Saudi Arabia (KSA) [5–7].
After that, MERS-CoV exhibited outbreaks in several re-
gions of the world [8–12]. Although MERS-CoV is
thought to be a zoonosis, probably camels act as a direct
source of human MERS-CoV infection [13, 14], most
cases are now due to human-to-human transmission [9,
11, 12, 15–17]. The virus was firstly nominated Human
Coronavirus Erasmus Medical Center/2012 (HCoV-EMC/
2012) [5], but after global consensus it was renamed
MERS-CoV [18].
In order to evaluate its current impact on global scien-
tific research production, a bibliometric analysis was per-
formed using available information indexed at most
common journals-indexing databases, such as Scopus.
Bibliometric analysis examines the progress of any topic
and offers a comprehensive assessment of scientific re-
search trends. In recent years, bibliometric analysis has
been extensively performed to assess scientific activities in
many fields, including infectious diseases such as Mayaro
virus fever [19], Zika virus [20], Ebola virus disease [21,
22], yellow fever disease [23], dengue [24], Malaria [25],
leishmaniasis [26, 27], influenza [28], and John Cunning-
ham virus [29]. To the best of knowledge of the author,
there has been no bibliometric study about MERS-CoV
research in the English literature. This study aimed to as-
sess the characteristics and quality of articles involving
MERS-CoV at global level. The study approach is
employed to assess MERS-CoV related research charac-
teristics such as countries, journals, research institutions,
and citation habits.
Methods
Publications used in this analysis were extracted from
the Scopus database developed by Elsevier in the
Netherlands. Scopus is a relatively large database com-
pared to PubMed and Web of Science [30] which con-
tains information for publications published in more
than 21,500 titles of which 20,000 are peer-reviewed
journals from more than 5,000 international publishers
[31]. Selected publications included “Middle East re-
spiratory syndrome coronavirus” or “MERS-CoV” or
“Human Coronavirus Erasmus Medical Center/2012” or
“HCoV-EMC/2012” as a part of its title, abstract, or key-
word from 2012 till the date of December 31, 2015 All
of these terms are used in one query. Publications as er-
rata or publications which their scope was not related to
MERS-CoV, and publications from 2016 were excluded
from the study. Research indicators for the assessment
of MERS-CoV research output were determined accord-
ing to the methods used previously in similar bibliomet-
ric studies [32–37]. Analysis parameters include date
(year) of publication, publication type, patterns of inter-
national collaboration, research institutions, journals,
impact factor (IF), h-index, language, and times cited.
International collaborations were considered when the
paper affiliation contained different countries.
To measure the impact and/or productivity of the re-
search published in the field of MERS-CoV, h-index and
IF were used as bibliometric indicators for this evalu-
ation. The h-index was introduced in literature in 2005
by Hirsch for the assessment of individual academic at-
tainment [38]. The h-index can more truthfully repre-
sent the author’s or country’s achievement; a higher h-
index shows that the publication s larger influential
power. The IF of the journals as reported in Journal Cit-
ation Reports® (JCR) 2014 was used [39]. Only the ten
top-ranked journals were considered and they were
shown in descending order from 1st to 10th using the
standard competition ranking (SCR), with the highest
absolute number of publications ranked 1, as obtained
on the day of data collection (March 4, 2016). Data col-
lection and analysis were performed on the same day in
order to avoid the possible bias came from update on
the database because the metrics are changing over time.
Parameters with the same number of publications were
given the same rank number.
Statistical analysis
The analysis was performed using descriptive statistics
in Microsoft Excel 2007, and SPSS statistical software
(SPSS for Windows, version 15, SPSS Inc Chicago, IL,
USA). The analysis involved the calculation of relative
frequencies, percentages, sum, and average.
Results
A total of 883 MERS-CoV-associated publications were re-
trieved in the study search. Nine publications were pub-
lished in 2012, 155 in 2013, 318 in 2014, and 401 in 2015.
Around sixty percent of total share was published as ori-
ginal articles, 13.3 % as reviews, 9.5 % as editorial materials,
7.5 % as letters, and the remaining being note, erratum, and
conference Paper. Among these articles, 829 (93.9 %) were
written in English, 18 (2.04 %) were in Korean, 12 (1.4 %)
were in Chinese, 10 (1.1 %) were in German, and the re-
mainder of articles were in a variety of other languages such
as French, Czech, Dutch, Greek, Polish, and Hungarian.
The MERS-CoV-associated publications were originated
from 92 countries/territories, indicating the international
spread of MERS-CoV research. Table 1 shows the 10 coun-
tries with the highest number of publications included in
the h-indices. Out of 883 publications, the USA was the
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largest contributor, with 319 (36.1 %) articles published
over 4 years; this was followed by KSA (113, 12.8 %), China
(103, 11.7 %), and the UK (93, 10.5 %). The total number
of citations for these publications has already achieved
8,015, with an average of 9.01 citations per each publica-
tion. The h-index for MERS-CoV-associated publications
was 48. The USA also have the highest h-index (32),
followed by KSA (26) and the UK (22). Netherland pro-
duced the greatest proportion of publications with inter-
national research collaboration (72.7 %) followed by the
UK (71 %) and Germany (69.1 %) out of the total number
of publications for each country (Table 1).
The MERS-CoV-associated publications were published
in 384 different journals, but most frequently in these jour-
nals: Journal of Virology (46), Emerging Infectious Diseases
(43), Eurosurveillance (36), and The Lancet Infectious
Diseases (35); (Table 2). The IF for journals including top 10
cited MERS-CoV publications ranged from 1.859 to 45.217.
Table 3 shows the top-cited publications published in
the field of MERS-CoV [2, 5, 6, 18, 40–46]. The 10 most
frequently cited articles have been cited more than 137
times from their initial publication year until March 4,
2016. The most frequently cited article (645 citations)
was published by Zaki et al. in 2012 in the New England
Journal of Medicine [5], followed by Assiri et al. [40]
which was published in the New England Journal of
Medicine in 2013. Majority of the top cited papers were
published in journals with high IF (IF > 10).
The contribution of the 10 most productive institutes
in MERS-CoV research from 2012 to 2015 is shown in
Table 4. Among the top 10 institutes, 4 institutes are
from the USA, 2 from KSA; and one from Hong Kong,
Netherland, UK, China and Germany respectively. The
University of Hong Kong had the maximum contribution
in terms of the total volume of publications with 68
articles, followed by the Ministry of Health Saudi Arabia
in KSA (63 articles) and Erasmus University Medical
Center in Netherland (47 articles).
Discussion
The current study showed a rapid increase in research
activities related to MERS-CoV in the past 4 years. The
USA and KSA were the most productive countries.
These results are not surprising because the USA has
played an important role in fostering international co-
operation on MERS-CoV research and control due to
the potential risk that this represents globally. Another
possible explanation for this is that the USA is the most
prolific country for scientific research in general in
previous bibliometric studies [19, 32–36]. It seems pos-
sible that these results are due to its size and economic
strength. The ten most prolific countries that were
involved in MERS-CoV research contains new nations
Table 1 Top ten countries/territories with scientific production on MERS-CoV research at Scopus (up to December 31, 2015)
SCR Countries/territories Total number of publications
for the whole period (%)
h-index Number (%) of publications
with international collaboration
1st United States 319 (36.1) 32 168 (52.7)
2nd Saudi Arabia 113 (12.8) 26 76 (67.3)
3rd China 103 (11.7) 19 63 (61.2)
4th United Kingdom 93 (10.5) 22 66 (71.0)
5th Hong Kong 71 (8.0) 18 47 (66.2)
6th Germany 68 (7.7) 21 47 (69.1)
7th Netherlands 55 (6.2) 21 40 (72.7)
8th South Korea 39 (4.4) 4 4 (10.3)
9th France 37 (4.2) 10 17 (45.9)
10th Australia 27 (3.1) 6 13 (48.1)
SCR standard competition ranking
Table 2 The 10 most published journals
SCRa Journal Frequency (%) IF b
1st Journal of Virology 46 (5.2) 4.439
2nd Emerging Infectious Diseases 43 (4.9) 6.751
3rd Eurosurveillance 36 (4.1) 5.722
4th The Lancet Infectious Diseases 35 (4.0) 22.433
5th MBio 34 (3.9) 6.786
6th The lancet 24 (2.7) 45.217
7th International Journal of
Infectious Diseases
20 (2.3) 1.859
8th Virus Research 17 (1.9) 2.324
9th Journal of the Korean
Medical Association
15 (1.7) NA
9th Journal of Infectious Diseases 15 (1.7) 5.997
SCR standard competition ranking, NA not available, IF impact factor
a Equal journals have the same ranking number, and then a gap is left in the
ranking numbers
b The impact factor was reported according to the journal citation reports
(JCR) 2014
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different from the familiar global ranking [47]. Through
the current study, KSA leadership in MERS-CoV global
research (12.8 % of the total) clearly stands up, most
likely due to the fact that it was in this country where
the virus originally isolated [5] and several outbreaks
have been reported in this country [10, 15, 48–51].
Other countries as those located in the Asia-Pacific such
as China, and South Korea have also increased their sci-
entific MERS-CoV research output in the last year
owing their new outbreaks [8, 52–56].
In the current study, the most commonly language
used in MERS-CoV research is English. Additionally, it
is because English is now used extensively and is consid-
ered one of the most widespread language in the world
[57], and the majority of journals indexed in Scopus are
published in English.
The findings of this study recognize the publications as-
sociated with the most important developments in the
field of MERS-CoV. This bibliometric analysis reveals that
the most cited article in MERS-CoV is the 2012 paper by
by Zaki et al [5], in New England Journal of Medicine. This
article reported the first isolated MERS-CoV in June 2012
from a Saudi male aged 60 years [5]. The second most
cited article was written in 2013 by Assiri et al [40]. The
authors reported a total of 23 cases related to MERS-CoV
infection in the eastern region of KSA. Furthermore, the 2
most highly cited articles were published in a relatively
high-IF journal (New England Journal of Medicine), which
has an IF of 55.873. Some previous study showed that the
IF of the journal was the strongest marker for citations
[58–60]. Findings of this study verify the close relationship
between IF and citations, and that the most cited articles
are usually published in journals that top the IF list, which
also helps keep the high IF of these journals [60]. How-
ever, the h-index was launched in 2005 [38] which have
been used to quantify of quality and impact of the scien-
tific research output of a researcher, countries, institu-
tions, and journals. The h-index was used in the current
Table 3 The top 10 cited publications
SCRa Authors Title Year of
publication
Source title Cited by IFb
1st Zaki et al [5] Isolation of a novel coronavirus from a man











3rd van Boheemen et al [45] Genomic characterization of a newly discovered
coronavirus associated with acute respiratory
distress syndrome in humans
2012 MBio 217 6.786
4th Raj et al [46] Dipeptidyl peptidase 4 is a functional receptor
for the emerging human coronavirus-EMC
2012 Nature 216 41.456
5th Reusken et al [41] Middle East respiratory syndrome coronavirus
neutralising serum antibodies in dromedary camels:





6th de Groot et al [18] Middle east respiratory syndrome coronavirus (MERS-CoV):




7th Assiri et al [2] Epidemiological, demographic, and clinical characteristics
of 47 cases of Middle East respiratory syndrome






8th Bermingham et al [6] Severe respiratory illness caused by a novel coronavirus,
in a patient transferred to the United Kingdom from the
Middle East, September 2012
2012 Eurosurveillance 148 5.722
9th Guery et al [42] Clinical features and viral diagnosis of two cases of
infection with Middle East Respiratory Syndrome
coronavirus: A report of nosocomial transmission
2013 The Lancet 139 45.217












SCR, Standard competition ranking; NA, Not available; IF, Impact factor
a Equal articles have the same ranking number, and then a gap is left in the ranking numbers
b The impact factor was reported according to the journal citation reports (JCR) 2014
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study for the top 10 countries. Of the top 10 countries, 5
had an h-index of 20 or more.
The large impact on scientific research output in
reference to MERS-CoV research replicates its global
influence as a potentially harmful disease. The most in-
teresting finding of this study was that the total number
of publications with the international collaboration for
each country are a bit greater than that found in earlier
bibliometric reports in different fields [33, 34, 36]. While
these earlier bibliometric studies have described the
importance of global collaboration, which considered as
the most effective strategy to increase citation rates
[36, 61–63]. Moreover, the global map of scientific collab-
oration networks and production lets researchers to con-
tribute for implementation of new strategy for controlling
MERS-CoV outbreaks to reduce morbidity and mortality
related with such outbreaks [10, 40, 50]. Furthermore, col-
laborative research clearly demonstrates the prioritization
in searches for a appropriate vaccine as well as effective
medications for treatment of MERS-CoV [64, 65].
The most important limitation lies in the fact that the
Scopus database was used to search for MERS-CoV. So
publications indexed in none Scopus-cited journals were
not studied. Another possible limitation to this study is
the use of absolute number of citations in ranking the
articles, instead of rankings based on average number of
citations per year. Furthermore, the number of research
output in 2015 may be rising because Scopus is still
open for new journals issues from this year.
Conclusions
Based on the Scopus database, the characteristics of the
MERS-CoV research output from 2012 to 2015 are in-
vestigated by means of bibliometric methods. There is a
rapid increase in research activities related to MERS-
CoV from 2012 to 2015. This study demonstrates that
the MERS-CoV related literature has grown to be more
extensive and global over the past 4 years. The bulk of
publications in the field of MERS-CoV research are pub-
lished by high-income countries such as the USA. Fur-
thermore, the USA, the UK and KSA may have higher
quality of articles according to the value of h-index.
These findings show the value of bibliometric method to
illustrate global research trends of MERS-CoV. Thus,
this study provides a helpful reference for medical virol-
ogists and epidemiologists, policy decision makers, aca-
demics, and MERS-CoV researchers. As MERS-CoV can
be considered a recent emerged disease, and a new re-
search topic, the study results characterize a ‘snapshot’
of this field at an early stage in its development.
Abbreviations
HCoV-EMC/2012, Human Coronavirus Erasmus Medical Center/2012; IF, impact
factor; IRB, institutional review board; KSA, Kingdom of Saudi Arabia; MERS-CoV,
Middle East respiratory syndrome coronavirus; SCR, standard competition ranking.
Funding sources
No funding was received for writing this study.
Availability of data and materials
Not applicable.
Authors’ contributions
SZ conceptualized, designed the methodology, and implemented the study,
and did the analysis and write-up. Then read, and approved the final
manuscript.
Competing interests
The author declares that he has no competing interests.
Consent for publication
Not applicable.
Ethics approval and consent to participate
As a bibliometric analysis, as there were no patients involved in this study,
there was no need for institutional review board (IRB) approval and it was
exempted.
Table 4 The top 10 highly productive and influential institutions in research on MERS-CoV field
SCRa Institution, country No. of publications (%)
1st The University of Hong Kong, Hong Kong 68 (7.7)
2nd Ministry of Health Saudi Arabia, KSA 63 (7.1)
3rd Erasmus University Medical Center, Netherland 47 (5.3)
4th Universitat Bonn, Germany 37 (4.2)
5th University College London, UK 36 (4.1)
6th Centers for Disease Control and Prevention, USA 30 (3.4)
7th The University of North Carolina at Chapel Hill, USA 28 (3.2)
8th Fudan University Shanghai Medical College, China 27 (3.1)
8th Alfaisal University, KSA 27 (3.1)
10th New York Blood Center, USA 26 (2.9)
10th Indiana University School of Medicine Indianapolis, USA 26 (2.9)
SCR standard competition ranking, KSA Kingdom of Saudi Arabia
a Equal institutions have the same ranking number, and then a gap is left in the ranking numbers
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